Effects of AMP579 and adenosine on L-type Ca2+ current in isolated rat ventricular myocytes

Acta Pharmacologica Sinica

Volumn 26, Issue 5, 2005, Pages 559-562

  Wang, Xiong ^a   Wu, Bo Wei ^a   Wu, Dong Mei ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Adenosine; AMP579; Cardiac myocytes; Heart ventricles; L type calcium channels; Patch clamp techniques

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 [7 [[1 [(3 CHLORO 2 THIENYL)METHYL]PROPYL]AMINO] 3H IMIDAZO[4,5 B]PYRIDIN 3 YL] N ETHYL 2,3 DIHYDROXYCYCLOPENTANECARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; CALCIUM CHANNEL L TYPE; ISOPRENALINE; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE CELL; HEART VENTRICLE; INHIBITION KINETICS; MALE; NONHUMAN; PATCH CLAMP; RAT;

ADENOSINE; ANIMALS; CALCIUM CHANNELS, L-TYPE; CARDIOTONIC AGENTS; CELL SEPARATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; IMIDAZOLES; INDOLES; MALE; MALEIMIDES; MYOCYTES, CARDIAC; PROTEIN KINASE C; PYRIDINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A1; XANTHINES;

EID: 18744390077     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00107.x     Document Type: Article

References (16)

1. Nakamura M, Zhao ZQ, Clark KL, Velez DV, Guyton RA, Vinter-Johansen J. A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium. Eur J Pharmacol 2000; 397: 197-205.
2. 2 receptor agonist. J Org Chem 2000; 65: 8114-9.
3. Budde JM, Velez DA, Zhao ZQ, Clark KL, Morris CD, Muraki S, et al. Comparative study of AMP579 and adenosine inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion. Cardiovasc Res 2000; 47: 294-305.
4. 2 receptors. J Cardiovasc Pharmacol 2001; 38: 474-81.
5. 2-receptor agonist AMP579: coronary hemodynamic and cardioprotective effects in the canine myocardium. J Cardiovasc Pharmacol 1999; 33: 701-10
6. 2 receptor agonist AMP579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 1998; 286: 611-8.
7. Pelleg A, Belardinelli C. Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc Res 1993; 27: 54-61.
8. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989; 32: 73-97.
9. 2+ exchange in cardiac myocytes: mediation by sulfhydryl groups? Am J Physiol 1994; 266; H909-19.
10. Hartzell HC, Simmons MA. Comparison of effects of acetylcholine on calcium and potassium currents in frog atrium and ventricle. J Physiol 1987; 89: 411-22.
11. 2+-antagonistic effects of adenosine in guinea-pig atrial cell. Am J Physiol 1988; 255: H872-8.
12. 2+ current by adenosine in ferret isolated right ventricular myocytes. J Physiol 1993; 471: 269-93.
13. Isenberg G, Belardinelli L. Ionic basis for the antagonism between adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ Res 1984; 55: 309-25.
14. 2+ current inhibition. Surgery 1993; 114: 334-42.
15. Shen JB, Pappano AJ. On the role of phosphatase in regulation of cardiac L-type calcium current by cyclic GMP. J Pharmacol Exp Ther 2002; 301: 501-6.
16. 2+ channel in the guinea-pig heart. Pflugers Arch 1985; 405: 285-93.